TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors
TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors
Recruiting · NCT07266298 · Registry updated 2025-12-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors | Solid Metastatic Tumor | Recruiting | Phase 1 | 2025-12-12 | NCT07266298 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Neowise Biotechnology | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer hosptial | Beijing | China | 1 |